English  |  正體中文  |  简体中文  |  2818385  
???header.visitor??? :  28050396    ???header.onlineuser??? :  578
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"chun jen liu"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 151-175 of 543  (22 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-01-24T09:31:54Z The risky body mass index ranges for significant hepatitis B viral load: A campus-based study Chiang C.-H.; Lai J.-S.; Sheu J.-C.; Yen L.-L.; CHUN-JEN LIU; Huang K.-C.
臺大學術典藏 2022-01-24T09:31:54Z Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: Results from 17-year follow-up of a population-based cohort Chao L.-T.; Wu C.-F.; Sung F.-Y.; Lin C.-L.; CHUN-JEN LIU; Huang C.-J.; Tsai K.-S.; Yu M.-W.
臺大學術典藏 2022-01-24T09:31:54Z Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update Liaw Y.-F.; Kao J.-H.; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M.
臺大學術典藏 2022-01-24T09:31:54Z Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy Liang C.-C.; Liu C.-H.; Lin Y.-L.; CHUN-JEN LIU; Chiang B.-L.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:53Z Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters Tseng T.-C.; CHUN-JEN LIU; Chen C.-L.; Wang C.-C.; Su T.-H.; Kuo S.F.-T.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:53Z Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese CHUN-JEN LIU
臺大學術典藏 2022-01-24T09:31:53Z Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma Kao J.-H.; CHUN-JEN LIU; Jow G.-M.; Chen P.-J.; Chen D.-S.; Chen B.-F.
臺大學術典藏 2022-01-24T09:31:53Z High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Tseng T.-C.; CHUN-JEN LIU; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:52Z Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission Lin C.-L.; Tseng T.-C.; Su T.-H.; CHUN-JEN LIU; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:52Z Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B Pan C.J.-H.; Wu H.-L.; Kuo S.F.-T.; Kao J.-H.; Tseng T.-C.; Liu C.-H.; Chen P.-J.; CHUN-JEN LIU; Chen D.-S.
臺大學術典藏 2022-01-24T09:31:52Z Impact of hepatitis B virus infection on metabolic profiles and modifying factors Hsu C.-S.; Liu C.-H.; Wang C.-C.; Tseng T.-C.; CHUN-JEN LIU; Chen C.-L.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:51Z Treatment of hepatitis C virus infection: Past, present and future CHUN-JEN LIU; Chen D.-S.
臺大學術典藏 2022-01-24T09:31:51Z Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:51Z Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load Tseng T.-C.; CHUN-JEN LIU; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:51Z Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:50Z Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy Sheng W.-H.; Hung C.-C.; Chang S.-Y.; CHUN-JEN LIU; Chen M.-Y.; Hsieh S.-M.; Kao J.-H.; Chen P.-J.; Chang S.-C.
臺大學術典藏 2022-01-24T09:31:50Z Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation Tseng T.-C.; CHUN-JEN LIU; Su T.-H.; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:50Z Erratum: Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update (Hepatology International (2012) 6 (531-561) DOI: 10.1007/s12072-012-9365-4) Liaw Y.-F.; Kao J.-H.; Piratvisuth T.; Chan H.L.Y.; Chien R.-N.; CHUN-JEN LIU; Gane E.; Locarnini S.; Lim S.-G.; Han K.-H.; Amarapurkar D.; Cooksley G.; Jafri W.; Mohamed R.; Hou J.-L.; Chuang W.-L.; Lesmana L.A.; Sollano J.D.; Suh D.-J.; Omata M.
臺大學術典藏 2022-01-24T09:31:49Z Hepatitis B virus reactivation in patients receiving cancer chemotherapy: Natural history, pathogenesis, and management CHUN-JEN LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:49Z IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; CHUN-JEN LIU; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:49Z Influences of tobacco and alcohol use on hepatocellular carcinoma survival Shih W.-L.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Chen P.-J.; CHUN-JEN LIU; Lin C.-L.; Yu M.-W.
臺大學術典藏 2022-01-24T09:31:49Z Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals CHUN-JEN LIU; Hsu C.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:48Z Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads Tseng T.-C.; CHUN-JEN LIU; Yang H.-C.; Su T.-H.; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏 2022-01-24T09:31:48Z Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients Yuan Q.; Song L.-W.; CHUN-JEN LIU; Li Z.; Liu P.-G.; Huang C.-H.; Yan Y.; Ge S.-X.; Wang Y.-B.; Peng C.-Y.; Zhang J.; Kao J.-H.; Chen D.-S.; Chen P.-J.; Xia N.-S.
臺大學術典藏 2022-01-24T09:31:48Z Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; CHUN-JEN LIU; Tseng T.-C.; Su T.-H.; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.

Showing items 151-175 of 543  (22 Page(s) Totally)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
View [10|25|50] records per page